History
QBIO – a research center of excellence in the field of clinical trials. QBIO was created on the basis and achievements of the Eco-Safety Research Centre.
DetailsHistory of the Centre
QBIO is a research and development center of excellence for full-cycle development in the field of clinical trials. QBIO was established on the basis and achievements of the Eco-Safety Research Centre.
Founded in 2014 by a team of experts with more than 20 years of experience, the Centre has become a leader in the organization and conduct of clinical trials in all phases, as well as bioequivalence and pharmacokinetic studies.
One of the main areas of activity is phase 1 clinical trials and bioequivalence studies, which are carried out on the basis of the Pharmacokinetic and Pharmacodynamic Research Center. The Centre includes the Bioanalytical Laboratory «QBioLab», specialized hospital departments, a research department and a biospecimen circulation service, whose work is carried out within the framework of a unified quality management system. To date, we have conducted more than 530 clinical trials in various fields of medicine, involving more than 25,000 subjects. Our partners are about 100 domestic and foreign pharmaceutical companies, research institutes and contract research organizations.
The Centre's team consists of more than 150 employees, including more than 40 principal investigators, 50 co-investigators in various medical fields, including 3 Doctors of Sciences and 10 Candidates of Sciences. The head of the team is Vasily Bogdanovich Vasilyuk, Professor, Doctor of Medical Sciences, who has conducted more than 190 clinical trials of all phases as a principal investigator. He is the author of more than 150 scientific publications in peer-reviewed journals. The medical base of the Centre is more than 4000 square meters, 2 branches, 10 Emergency Services and Health Centers at enterprises in St. Petersburg and Leningrad region, 4 outpatient departments, 3 inpatient departments, a surgical unit with an intensive care unit and diagnostic units.
In recent years, the Eco-Safety Research Centre has become the operator of the QBio biomedical platform, which enables integrated management of all drug development processes. This allows our customers to complete their turnkey projects in a short time, with an optimal budget and in full compliance with local and international regulations.
